NCT05539677 Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research Status RECRUITING Phase N/A
NCT05539118 Interferon-α1b Combined With Toripalimab and Anlotinib Hydrochloride in Advanced Unresectable Melanoma Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT05538130 A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT05527795 Predictive Clinical Features for Response to Adjuvant Immunotherapy in Stage II,III and IV Resected Melanoma Status RECRUITING Phase N/A
NCT05522660 Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer Status RECRUITING Phase PHASE3
NCT05520294 Evaluating the Effects of Cannabis Use and Circulating Cannabinoids on Tumor Infiltrating Lymphocytes in Malignant Melanoma Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05512481 Camrelizumab Plus Apatinib and Temozolomide as Neoadjuvant in High Risk Acral Melanoma Status RECRUITING Phase PHASE2
NCT05500508 Oral AMXT 1501 Dicaprate in Combination With IV DFMO Status TERMINATED Phase PHASE1/PHASE2
NCT05496192 A Study of Nivolumab Intravenous (IV) to Subcutaneous (SC) Switch in Adjuvant Melanoma and Bladder Cancer Status WITHDRAWN Phase PHASE2
NCT05488483 A Study of Tumor Imaging With Multispectral Optoacoustic Tomography Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05483400 Open Label Phase 2 Basket Trial With Atezolizumab and Tiragolumab in Solid Tumors Status RECRUITING Phase PHASE2
NCT05478473 Clinical Study of Chidamide Combined With Toripalimab in the Treatment of Advanced Melanoma Status UNKNOWN Phase NA
NCT05470283 Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05461430 Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) Status COMPLETED Phase N/A
NCT05457842 A Study to Find the Best Dose of ASP5354 to Show Lymph Nodes in People With Breast Cancer or Melanoma During Surgery Status TERMINATED Phase PHASE2
NCT05451407 Efficacy and Safety of TQB2618 Injection Combined With Toripalimab Injection in Patients With Advanced Melanoma Status UNKNOWN Phase PHASE1
NCT05432622 A Study of Treatment Patterns and Outcomes in Participants With Stage IIIA Melanoma Receiving Adjuvant Systemic Therapy Status COMPLETED Phase N/A
NCT05429866 Immunological Variables Associated to ICI Toxicity in Cancer Patients Status UNKNOWN Phase PHASE2
NCT05429138 Ovarian Reserve and Semen Parameters Evolution During Adjuvant Therapy in Melanoma Status RECRUITING Phase N/A